Skip to main content
. 2023 Dec 22;72(51):1357–1364. doi: 10.15585/mmwr.mm7251a1

FIGURE 1.

The figure is a flowchart indicating the review process of COVID-19 rebound studies on the basis of specific selection criteria that were published during February 1, 2020–November 29, 2023.

Review of SARS-CoV-2 rebound studies based on specific selection criteria*,† — February 1, 2020–November 29, 2023

* Keywords used in search were, “Paxlovid rebound,” “SARS-CoV-2 viral rebound,” “SARS-CoV-2 rebound,” “nirmatrelvir/ritonavir rebound,” “molnupiravir rebound,” “SARS-CoV-2 infection rebound,” “SARS-CoV-2 viral load rebound,” “rebound phenomenon,” “SARS-CoV-2 viral kinetics,” “SARS-CoV-2 virologic rebound,” and “SARS-CoV-2 clinical rebound.”

† Studies were excluded if they were not related to COVID-19, related to nonrebound aspects of COVID-19, were preprints, editorials, case reports, studies of ancillary medications, or other publications not describing original data or analyses of rebound data.